Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2007 May 01;10418:7444-8. doi: 10.1073/pnas.0702136104.
Show Gene links
Show Anatomy links
Small-molecule synergist of the Wnt/beta-catenin signaling pathway.
Zhang Q
,
Major MB
,
Takanashi S
,
Camp ND
,
Nishiya N
,
Peters EC
,
Ginsberg MH
,
Jian X
,
Randazzo PA
,
Schultz PG
,
Moon RT
,
Ding S
.
???displayArticle.abstract???
The Wnt/beta-catenin signaling pathway regulates cell fate and behavior during embryogenesis, adult tissue homeostasis, and regeneration. When inappropriately activated, the pathway has been linked to colorectal cancer and melanoma, and when attenuated it may contribute to Alzheimer's disease and osteoporosis. Small molecules that modulate Wnt signaling will likely provide new insights into the regulation of this key developmental pathway and ultimately provide pharmacological agents to control Wnt signaling in vivo. To this end, we screened a library of 100,000 small molecules for activity in a cell-based assay of Wnt/beta-catenin signaling and discovered a purine derivative, QS11, that synergizes with Wnt-3a ligand in the activation of Wnt/beta-catenin signal transduction. Through affinity chromatography and subsequent functional assays, we showed that QS11 binds and inhibits the GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1), suggesting that QS11 modulates Wnt/beta-catenin signaling through an effect on protein trafficking. Consistent with its function as an ARFGAP inhibitor, QS11 inhibits migration of ARFGAP overexpressing breast cancer cells.
Bejsovec,
Wnt pathway activation: new relations and locations.
2005, Pubmed
Bejsovec,
Wnt pathway activation: new relations and locations.
2005,
Pubmed
Bernards,
GAP control: regulating the regulators of small GTPases.
2004,
Pubmed
Christian,
Xwnt-8, a Xenopus Wnt-1/int-1-related gene responsive to mesoderm-inducing growth factors, may play a role in ventral mesodermal patterning during embryogenesis.
1991,
Pubmed
,
Xenbase
DasGupta,
Functional genomic analysis of the Wnt-wingless signaling pathway.
2005,
Pubmed
Dell'Angelica,
GGAs: a family of ADP ribosylation factor-binding proteins related to adaptors and associated with the Golgi complex.
2000,
Pubmed
Ding,
A combinatorial scaffold approach toward kinase-directed heterocycle libraries.
2002,
Pubmed
Dove,
Screening for content--the evolution of high throughput.
2003,
Pubmed
Emami,
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
2004,
Pubmed
Hung,
Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
2005,
Pubmed
Kanoh,
Arfaptin 1, a putative cytosolic target protein of ADP-ribosylation factor, is recruited to Golgi membranes.
1997,
Pubmed
Klausner,
Brefeldin A: insights into the control of membrane traffic and organelle structure.
1992,
Pubmed
Klein,
A molecular mechanism for the effect of lithium on development.
1996,
Pubmed
,
Xenbase
Kwok,
A small-molecule screen in C. elegans yields a new calcium channel antagonist.
2006,
Pubmed
Lepourcelet,
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.
2004,
Pubmed
,
Xenbase
Liu,
A small-molecule agonist of the Wnt signaling pathway.
2005,
Pubmed
,
Xenbase
Makler,
ADP-ribosylation factor-directed GTPase-activating protein. Purification and partial characterization.
1995,
Pubmed
McMahon,
Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis.
1989,
Pubmed
,
Xenbase
Moon,
From cortical rotation to organizer gene expression: toward a molecular explanation of axis specification in Xenopus.
1998,
Pubmed
,
Xenbase
Moon,
WNT and beta-catenin signalling: diseases and therapies.
2004,
Pubmed
Nusse,
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.
1982,
Pubmed
Onodera,
Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
2005,
Pubmed
Pai,
Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.
2004,
Pubmed
Palacios,
ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly.
2002,
Pubmed
Park,
Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
2005,
Pubmed
Polakis,
Wnt signaling and cancer.
2000,
Pubmed
Santy,
Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D.
2001,
Pubmed
Sato,
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.
2004,
Pubmed
Shan,
Identification of a specific inhibitor of the dishevelled PDZ domain.
2005,
Pubmed
,
Xenbase
Tanaka,
An unbiased cell morphology-based screen for new, biologically active small molecules.
2005,
Pubmed
Tsai,
Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
1998,
Pubmed
